Breast CAncer

Polypharmacy Increases Risk of Post Chemotherapy Inpatient Hospitalization for Older Patients

By

Joyce Pagan

Publish Date April 7, 2020

Patients with cancer aged 65 and older are likely to be taking 5 or more medications before treatment with IV chemotherapy, which can complicate posttreatment care.

Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer Patients

Publish Date April 3, 2020

[Breast Cancer: Targets and Therapy] A retrospective chart review of a cohort of patients with TNBC found that tumor size and nodal status is associated with DFS, and radiotherapy technique and fractionation protocol were not associated with differences in either DFS or OS.

Causal Link Suggested for IGF-1 Concentrations, Breast Cancer

Publish Date March 24, 2020

In Mendelian randomization analyses, increase in genetically predicted IGF-1 linked to breast cancer.

Invasive Breast Cancer Detection Up With Abbreviated Breast MRI

Publish Date March 23, 2020

Detection rate for invasive breast cancer significantly higher with MRI versus digital breast tomosynthesis.

Sustained Favorable Outcomes Found With Digital Breast Tomosynthesis

Publish Date March 20, 2020

Recall rate percentage significantly lower and cancer detection rate significantly higher for DBT versus DM

Genetic Mutations ID’d in Breast Cancer After Menopause

Publish Date March 19, 2020

3.55 percent of unselected postmenopausal women with breast cancer have pathogenic variants.

Genetic Testing Proposed for All Women ≤65 With Breast Cancer

Publish Date March 17, 2020

Expanded testing could increase detection of carriers for BRCA1/2, mutations in other predisposition genes.

Dairy Milk Tied to Higher Breast Cancer Risk

Publish Date March 17, 2020

Findings similar regardless of full-fat or reduced-fat milk consumption.

Patient, Provider Perspectives on Incorporating Prognosis into Shared Decision Making for Women With mBC

By

Susan Moench, PhD, PA-C

Publish Date March 16, 2020

In this study, nurse participants emphasized the connection between the early delivery of prognostic information and the optimal delivery of palliative care.

Addition of ICIs to Neoadjuvant Chemotherapy in High-Risk Breast Cancer Supported by Results of Phase 3 Trial

By

Susan Moench, PhD, PA-C

Publish Date March 12, 2020

Results of earlier-phase trials provided support for this phase 3 trial in triple-negative, stage II/III breast cancer.